These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1187 related items for PubMed ID: 24745551

  • 1. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
    Feng W, Nie W, He C, Zhou X, Chen L, Qiu K, Wang W, Yin Z.
    ACS Appl Mater Interfaces; 2014 Jun 11; 6(11):8447-60. PubMed ID: 24745551
    [Abstract] [Full Text] [Related]

  • 2. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X, Wang Y, Peng B.
    Chem Asian J; 2014 Jan 11; 9(1):319-27. PubMed ID: 24115568
    [Abstract] [Full Text] [Related]

  • 3. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y, Yang W, Chang B, Hu H, Fang X, Sha X.
    Eur J Pharm Biopharm; 2013 Nov 11; 85(3 Pt A):406-12. PubMed ID: 23816639
    [Abstract] [Full Text] [Related]

  • 4. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q, Zhao H, Li D, Liu L, Du S.
    Colloids Surf B Biointerfaces; 2017 Jan 01; 149():138-145. PubMed ID: 27750088
    [Abstract] [Full Text] [Related]

  • 5. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy.
    Gonçalves M, Figueira P, Maciel D, Rodrigues J, Qu X, Liu C, Tomás H, Li Y.
    Acta Biomater; 2014 Jan 01; 10(1):300-7. PubMed ID: 24075886
    [Abstract] [Full Text] [Related]

  • 6. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites.
    Yang H, Chen Y, Chen Z, Geng Y, Xie X, Shen X, Li T, Li S, Wu C, Liu Y.
    Biomater Sci; 2017 May 02; 5(5):1001-1013. PubMed ID: 28327716
    [Abstract] [Full Text] [Related]

  • 7. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z, He D, He X, Wang K, Yang X, Qing Z, Zhou Q.
    Langmuir; 2013 Oct 15; 29(41):12804-10. PubMed ID: 24073830
    [Abstract] [Full Text] [Related]

  • 8. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
    Chai F, Sun L, He X, Li J, Liu Y, Xiong F, Ge L, Webster TJ, Zheng C.
    Int J Nanomedicine; 2017 Oct 15; 12():1791-1802. PubMed ID: 28424550
    [Abstract] [Full Text] [Related]

  • 9. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility.
    Feng W, Zhou X, He C, Qiu K, Nie W, Chen L, Wang H, Mo X, Zhang Y.
    J Mater Chem B; 2013 Nov 21; 1(43):5886-5898. PubMed ID: 32261055
    [Abstract] [Full Text] [Related]

  • 10. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J, Sun Y, Tian B, Li K, Wang L, Liang Y, Han J.
    Colloids Surf B Biointerfaces; 2016 Aug 01; 144():293-302. PubMed ID: 27107383
    [Abstract] [Full Text] [Related]

  • 11. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H, Guo J, Sun Y, Chang B, Ren Q, Yang W.
    Int J Pharm; 2011 Dec 15; 421(2):388-96. PubMed ID: 22001840
    [Abstract] [Full Text] [Related]

  • 12. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
    Moreira AF, Gaspar VM, Costa EC, de Melo-Diogo D, Machado P, Paquete CM, Correia IJ.
    Eur J Pharm Biopharm; 2014 Nov 15; 88(3):1012-25. PubMed ID: 25229810
    [Abstract] [Full Text] [Related]

  • 13. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q, Chen X, Shi H, Dong G, Zhou M, Wang T, Xin H.
    Colloids Surf B Biointerfaces; 2017 Dec 01; 160():527-534. PubMed ID: 29024917
    [Abstract] [Full Text] [Related]

  • 14. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT, Liu ZK, Zhu QL, Rong XH, Liang CL, Wang J, Ma D, Sun J, Wang GH.
    Colloids Surf B Biointerfaces; 2017 Jul 01; 155():41-50. PubMed ID: 28407530
    [Abstract] [Full Text] [Related]

  • 15. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y, Ang CY, Li M, Tan SY, Qu Q, Luo Z, Zhao Y.
    ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):18179-87. PubMed ID: 26221866
    [Abstract] [Full Text] [Related]

  • 16. Facile development of nanocomplex-in-nanoparticles for enhanced loading and selective delivery of doxorubicin to brain.
    Hefnawy A, Khalil IA, El-Sherbiny IM.
    Nanomedicine (Lond); 2017 Dec 19; 12(24):2737-2761. PubMed ID: 29135325
    [Abstract] [Full Text] [Related]

  • 17. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP, Jain K, Jain NK.
    Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363
    [Abstract] [Full Text] [Related]

  • 18. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
    Zheng Q, Lin T, Wu H, Guo L, Ye P, Hao Y, Guo Q, Jiang J, Fu F, Chen G.
    Int J Pharm; 2014 Mar 10; 463(1):22-6. PubMed ID: 24393764
    [Abstract] [Full Text] [Related]

  • 19. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A, Zahid F, Zhan G, Yi P, Yang H, Gan L, Yang X.
    Int J Nanomedicine; 2018 Mar 10; 13():1029-1040. PubMed ID: 29497295
    [Abstract] [Full Text] [Related]

  • 20. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H.
    Mater Sci Eng C Mater Biol Appl; 2018 Mar 01; 84():108-117. PubMed ID: 29519418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.